About
CureMetrix develops FDA-cleared AI software that detects and localizes breast arterial calcifications on mammograms, enabling cardiovascular risk assessment during routine breast cancer screening.
Explore CureMetrix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.